Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ankur Pandya

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in CanadaMonika Wagner, Mireille Goetghebeur, Elizabeth Merikle, et al.
Journal of the American Heart Association|September 14, 2022
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac AmyloidosisYin Ge, Ankur Pandya, Sarah A M Cuddy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information AnalysisXiao Zang, Hawre Jalal, Emanuel Krebs, et al.
Annals of Internal Medicine|May 29, 2023
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United StatesGeorge Goshua, Cecelia Calhoun, Satoko Ito, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2020
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?Ankur Pandya, Djøra I Soeteman, Ajay Gupta, et al.
Plos One|February 4, 2016
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up StrokeAnkur Pandya, Ashley A Eggman, Hooman Kamel, et al.
JAMA|September 24, 2025
Insurance Dynamics During Childhood in the Fragmented US Health SystemYe Shen, Benjamin D Sommers, Laura A Hatfield, et al.
Radiology|September 17, 2014
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patientsAnkur Pandya, Ajay Gupta, Hooman Kamel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United StatesAmy K O'Sullivan, Ankur Pandya, George Papadopoulos, et al.
Journal of Cardiac Failure|November 8, 2025
Cost-Effectiveness Analysis of Guideline-Directed Medical Therapy Uptitration After Acute Decompensated Heart Failure From US and UK perspectivesChing-Hsuan Lin, Brandon W Yan, Victoria Yeung, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in CanadaMonika Wagner, Mireille Goetghebeur, Elizabeth Merikle, et al.
Journal of the American Heart Association|September 14, 2022
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac AmyloidosisYin Ge, Ankur Pandya, Sarah A M Cuddy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information AnalysisXiao Zang, Hawre Jalal, Emanuel Krebs, et al.
Annals of Internal Medicine|May 29, 2023
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United StatesGeorge Goshua, Cecelia Calhoun, Satoko Ito, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2020
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?Ankur Pandya, Djøra I Soeteman, Ajay Gupta, et al.
Plos One|February 4, 2016
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up StrokeAnkur Pandya, Ashley A Eggman, Hooman Kamel, et al.
JAMA|September 24, 2025
Insurance Dynamics During Childhood in the Fragmented US Health SystemYe Shen, Benjamin D Sommers, Laura A Hatfield, et al.
Radiology|September 17, 2014
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patientsAnkur Pandya, Ajay Gupta, Hooman Kamel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United StatesAmy K O'Sullivan, Ankur Pandya, George Papadopoulos, et al.
Journal of Cardiac Failure|November 8, 2025
Cost-Effectiveness Analysis of Guideline-Directed Medical Therapy Uptitration After Acute Decompensated Heart Failure From US and UK perspectivesChing-Hsuan Lin, Brandon W Yan, Victoria Yeung, et al.
Pageof 13